Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2012.07.21
关于控股子公司获得药品GMP证书的通告
2012.07.14
关于股东回报妄想事宜的论证报告
2012.07.14
关于召开2012年第二次暂时股东大会的通知通告
2012.07.14
关于向银行申请专项授信额度的通告
2012.07.14
第二届监事会第十五次聚会决议通告
2012.07.14
未来三年(2012-2014年)股东分红回报妄想
2012.07.14
第二届董事会第十六次聚会决议通告
2012.06.15
关于控股子公司完成工商变换挂号的通告
2012.06.09
关于控股子公司成都深瑞畜产品有限公司投产的通告
2012.05.31
中国中投证券有限责任公司关于公司拟以超募资金受让子公司股权有关事项的核查意见
第一页
上一页
126
127
128
129
130
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】